GridAI Technologies (GRDX) Accumulated Depreciation (2020 - 2024)
GridAI Technologies' (GRDX) quarterly Accumulated Depreciation came in at $87818.0 in Q4 2024, up 19.88% on a YoY basis from $73253.0 in Q1 2024, and little changed quarter-over-quarter from $87818.0 in Q3 2024.
Analysis
GridAI Technologies (GRDX) Accumulated Depreciation (2020 - 2024) Analysis & Trends
GridAI Technologies (GRDX) has reported Accumulated Depreciation for 5 consecutive years, with $87818.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Accumulated Depreciation rose 19.88% year-over-year to $87818.0; the trailing twelve-month figure through Dec 2024 stood at $87818.0 (up 19.88% YoY), and the FY2024 full-year result was $87818.0, up 19.88% from the prior year.
- Accumulated Depreciation was little changed at $87818.0 in Q4 2024 per GRDX's latest filing, from $87818.0 in the prior quarter.
- Across five years, Accumulated Depreciation topped out at $87818.0 in Q3 2024 and bottomed at $7430.0 in Q3 2021.
- Historically, Accumulated Depreciation has averaged $52320.0 across 5 years, with a median of $51297.0 in 2023.
- The sharpest annual moves came in 2021 and 2022: Accumulated Depreciation slumped 61.7% in 2021, then soared 393.42% in 2022.
- Over 5 years, Accumulated Depreciation stood at $38403.0 in 2020, then plunged by 61.7% to $14708.0 in 2021, then soared by 199.01% to $43979.0 in 2022, then soared by 66.56% to $73253.0 in 2023, then rose by 19.88% to $87818.0 in 2024.
- According to Business Quant data, Accumulated Depreciation over the past three periods registered $87818.0, $87818.0, and $86483.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | GridAI Technologies | 19.07 Mn | 19.07 Mn | -36,514.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 87,818.00 |
| Sep 30, 2024 | 87,818.00 |
| Jun 30, 2024 | 86,483.00 |
| Mar 31, 2024 | 81,032.00 |
| Dec 31, 2023 | 73,253.00 |
| Sep 30, 2023 | 65,934.00 |
| Jun 30, 2023 | 58,616.00 |
| Mar 31, 2023 | 51,297.00 |
| Dec 31, 2022 | 43,979.00 |
| Sep 30, 2022 | 36,661.00 |
| Jun 30, 2022 | 29,343.00 |
| Mar 31, 2022 | 22,025.00 |
| Dec 31, 2021 | 14,708.00 |
| Sep 30, 2021 | 7,430.00 |
| Dec 31, 2020 | 38,403.00 |